Upcoming maintenance: ProQuest will be unavailable 10:00 PM ET Saturday, Aug 9 - 6:00 AM ET Sunday, Aug 10. ReadMore

Document Preview Unavailable

The FDA-approved drug cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replication

Iart, Luca Shytaj; Fares, Mohamed; Lucic, Bojana; Gallucci, Lara; Tolba, Mahmoud M; et al.  bioRxiv, Mar 9, 2021.

You might have access to this document